Author： Phan C Sanders DB Siddiqi ZA
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.14, 2008-10, pp. : 2545-2551
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Immunomodulatory treatment for myasthenia gravis
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :
Access to resources
Recommend
Myasthenia Gravis: Therapy Is Complex
Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. :
Mouse Models of Myasthenia Gravis
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :
Clinical Pharmacokinetics of Mycophenolate Mofetil
By Bullingham R.E.S. Nicholls A.J. Kamm B.R.
Clinical Pharmacokinetics, Vol. 34, Iss. 6, 1998-06 ,pp. :
The safety of mycophenolate mofetil in pregnancy
By Pisoni Cecilia N D'Cruz David P
Expert Opinion on Drug Safety, Vol. 7, Iss. 3, 2008-05 ,pp. :